Literature DB >> 18403403

Patient perceptions about illness self-management in ANCA-associated small vessel vasculitis.

C T Thorpe1, R F DeVellis, S J Blalock, S L Hogan, M A Lewis, B M DeVellis.   

Abstract

OBJECTIVES: To characterize patient perceptions, related to eight self-management behaviours relevant for adults with ANCA-associated small vessel vasculitis (ANCA-SVV), and to determine if these perceptions were associated with performance of each behaviour.
METHODS: Adults with ANCA-SVV (n = 202) completed a self-administered questionnaire that assessed eight self-management behaviours (adherence to recommendations for medication, health service use, diet, exercise, infection avoidance and symptom monitoring; prompt reporting of symptoms and side effects; and adjusting activities in response to symptoms), perceptions about these behaviours, socio-demographics, clinical factors and social desirability bias. Descriptive statistics were generated to characterize patients' perceptions about difficulty of, importance of, and specific barriers to performing each behaviour. Regression analyses explored whether these variables were associated with performing each behaviour, controlling for potential confounders.
RESULTS: With few exceptions, higher perceived importance and lower perceived difficulty of each behaviour were associated with more frequent performance of the behaviour. For each behaviour, several specific barriers were frequently endorsed by patients and a number of these were associated with lower levels of self-management.
CONCLUSION: This study reveals that patient perceptions about the illness and its treatment influence ANCA-SVV self-management. Perceived barriers to medication, health services, diet and exercise adherence were similar to those in other illnesses. This study also provides insight into barriers experienced by patients in performing behaviours (infection avoidance, symptom monitoring, reporting symptoms and side-effects and adjusting activities) not often previously studied. How the identification of these barriers can help inform future interventions for ANCA-SVV patients is to be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403403      PMCID: PMC4084613          DOI: 10.1093/rheumatology/ken126

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  25 in total

1.  Controlling the rate of Type I error over a large set of statistical tests.

Authors:  H J Keselman; Robert Cribbie; Burt Holland
Journal:  Br J Math Stat Psychol       Date:  2002-05       Impact factor: 3.380

2.  Treatment of ANCA-associated vasculitis.

Authors:  Carol A Langford
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

3.  The role of the Health Belief Model in amputees' self-evaluation of adherence to diabetes self-care behaviors.

Authors:  D T Pham; F Fortin; M F Thibaudeau
Journal:  Diabetes Educ       Date:  1996 Mar-Apr       Impact factor: 2.140

4.  A comparison of views of individuals with type 2 diabetes mellitus and diabetes educators about barriers to diet and exercise.

Authors:  J A Shultz; M A Sprague; L J Branen; S Lambeth
Journal:  J Health Commun       Date:  2001 Apr-Jun

Review 5.  A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease.

Authors:  S A Newell; J A Bowman; J D Cockburn
Journal:  Prev Med       Date:  1999-12       Impact factor: 4.018

6.  Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.

Authors:  K Andrassy; A Erb; J Koderisch; R Waldherr; E Ritz
Journal:  Clin Nephrol       Date:  1991-04       Impact factor: 0.975

Review 7.  Methodological issues in diabetes research. Measuring adherence.

Authors:  S B Johnson
Journal:  Diabetes Care       Date:  1992-11       Impact factor: 19.112

8.  Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Joachim Gutfleisch; Hartmut H Peter; Heiner H Raspe; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2002-06-15

Review 9.  Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis.

Authors:  David R W Jayne
Journal:  Cleve Clin J Med       Date:  2002       Impact factor: 2.321

10.  Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Authors:  Carolyn T Thorpe; Robert F Devellis; Megan A Lewis; Susan J Blalock; Susan L Hogan; Brenda M Devellis
Journal:  Arthritis Rheum       Date:  2007-10-15
View more
  8 in total

1.  Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis.

Authors:  Carolyn T Thorpe; Joshua M Thorpe; Tao Jiang; Dylan Atkinson; Yihuang Kang; Loren J Schleiden; Delesha M Carpenter; Julie Anne G McGregor; Susan L Hogan
Journal:  Semin Arthritis Rheum       Date:  2017-08-10       Impact factor: 5.532

2.  Economic and objective burden of caregiving on informal caregivers of patients with systemic vasculitis.

Authors:  Joehl T Nguyen; Courtney Roberts; Carolyn T Thorpe; Joshua M Thorpe; Susan L Hogan; Julie McGregor; Lorie Geryk; Delesha M Carpenter
Journal:  Musculoskeletal Care       Date:  2019-03-22

3.  Predictors of medication non-adherence for vasculitis patients.

Authors:  Delesha M Carpenter; Susan L Hogan; Robert F Devellis
Journal:  Clin Rheumatol       Date:  2013-01-12       Impact factor: 2.980

4.  The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire.

Authors:  Janice Mooney; Nicola Spalding; Fiona Poland; Peter Grayson; Renee Leduc; Carol A McAlear; Rachel L Richesson; Denise Shereff; Peter A Merkel; Richard A Watts
Journal:  Rheumatology (Oxford)       Date:  2014-03-12       Impact factor: 7.580

5.  Impact of caring for someone with a rare rheumatic condition, views from patients and informal carers-the need for cat-like vigilance.

Authors:  Janice Mooney; Karly Graham; Richard A Watts
Journal:  Rheumatol Adv Pract       Date:  2019-02-01

6.  Addressing the transition to a chronic condition: exploring independent adoption of self-management by patients with ANCA-associated vasculitis.

Authors:  Ian Litchfield; Sheila Greenfield; Lorraine Harper
Journal:  Rheumatol Adv Pract       Date:  2021-11-04

7.  Exploring the educational needs of patients with systemic vasculitis using the educational needs assessment tool.

Authors:  Sara Brolin; Elisabet Welin; Björn Lövström; Annette Bruchfeld; Iva Gunnarsson; Susanne Pettersson
Journal:  Rheumatol Adv Pract       Date:  2022-08-11

8.  Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility study.

Authors:  Lorraine Harper; Matthew David Morgan; Dimitrios Chanouzas; Hollie K Caulfield; Linda Coughlan; Caroline Dean; Kate Fletcher; Fiona Cramp; Sheila Greenfield; Catherine A Hewitt; Natalie J Ives; Sue Jowett; Amanda Daley
Journal:  BMJ Open       Date:  2018-10-30       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.